Wearable sensor developer MC10 raises $9.2m

MC10, a Lexington, Mass.–based wearable sensor developer, raised $9.2 million in an offering of promissory notes and warrants convertible into preferred stock to 18 investors, according to regulatory filing. The flexible electronics company still needs to raise $767,038 to reach the offering’s $10 million total. MC10’s BioStamp wearable sensors collect and transmit biometric data, allowing

Titan Medical closes $2m deal with Chinese investor

Titan Medical (TSX:TMD) said today that it closed a deal with Longtai Medical to convert a $2 million distributorship deposit to equity. The move makes Longtai the robotic surgical company’s largest shareholder. In May of 2015, Titan Medical and Longtai, a subsidiary of Chinese medical device distributor Ningbo Long Hengtai International Trade Co., inked a deal to

Sirtex swings to a loss after ‘challenging’ year

Shares in Australian cancer treatment developer Sirtex Medical (ASX:SRX) plunged more than 15% yesterday after the company posted a net loss of -A$26.9 million in 2016, compared to a profit of A$54 million the year before. Sirtex has faced a barrage of obstacles this year, including a number of clinical trials that failed to meet primary endpoints.

Fujifilm announces U.S. customer wins for Synapse imaging system

Fujifilm Medical Systems U.S.A. said today that seven U.S. healthcare systems are picking up various products from the company’s Synapse enterprise imaging portfolio. The health systems includeHackensack Meridian Health and West Virginia University Health System – two of the largest healthcare networks in the mid-Atlantic region. Products bought include the Synapse 5 PACS, Synapse VNA, Synapse

Medpace announces $60M stock repurchase agreement

Medpace Holdings (Nasdaq: MEDP) is spending about $60.5 million to repurchase stock. The stock repurchase agreement with Cinven Capital Management (V) General Partner Limited, announced yesterday, involves Medpace repurchasing 2 million shares of stock at a price of $30.27 per share. The transaction is expected to close tomorrow, subject to customary closing conditions. The company’s stock

Stratasys shares steady on Q2 beat

Shares in Stratasys have fallen slightly today, even as the 3D printing and additive manufacturing company met expectations on Wall Street with its second quarter earnings results. The Eden Prairie, Minn.–based company posted losses of $6.2 million, or 11¢ per share, on sales of $170 million for the 3 months ended June 30, seeing losses

Avinger shares slide on Q2 miss

Shares in Avinger (NSDQ:AVGR) fell today after the medical device developer missed expectations on Wall Street with its second quarter earnings results. The Redwood City, Calif.-based company posted losses of $12.8 million, or 54¢ per share, on sales of $2.5 million for the 3 months ended June 30, seeing losses shrink 5.2% while sales shrunk 47.5% compared

Want to sell your medtech startup? Be one of these three things

Peter Stebbins meets with a lot of medtech startups as medical device transactions lead at Johnson & Johnson Innovation in Boston. Often, they could benefit from a better grasp of what a buyer is looking for. “It’s not infrequent that someone with an idea perceives it should make sense to J&J, but they don’t understand where our

Teleflex shares rise on Q2 beat and raise

Shares in Teleflex (NYSE:TFX) rose today after the medical device maker topped expectations on Wall Street with its 2nd quarter earnings results, providing lifted guidance for the rest of its fiscal year. The Wayne, Pa.-based company posted profits of $78 million, or $1.67 per share, on sales of $528.6 million for the 3 months ended June 30,

Integer Holdings: What you need to know

Greatbatch and Lake Region Medical merged nearly two years ago to become Integer Holdings Co., a giant medical device contract manufacturer that could theoretically do almost anything for an OEM. But can this colossus of a company execute on its expanded capabilities? When Greatbatch and Lake Region Medical merged in 2015, company officials decided they

Pages: 1 2 3

Medtech stories we missed this week: July 28, 2017

From Accenture’s AI-powered app to help the visually impaired to Rayovac getting clearance from Health Canada, here are seven medtech stories we missed this week but still thought were worth mentioning. 1. Accenture touts AI-powered app for visually impaired Accenture announced in a July 28 press release that it has developed an artificial intelligence–powered way to

Integer misses expectations on Q2 profits, but grows revenue

Medical device contract manufacturing giant Integer Holdings Co. (NYSE: ITGR) reported a mixed bag when it came to second-quarter results. Nearly two years after Greatbatch and Lake Region Medical merged to create Frisco, Texas–based Integer, sales are growing, but second-quarter profits did not meet analysts’ expectations, according to earnings released yesterday evening. Integer earned $3.0

Wisconsin biotech industry optimistic about state’s Foxconn win

Wisconsin’s biotech industry sees opportunity in Taiwanese electronics giant Foxconn’s decision to spend $10 billion on a 3,000-employee plant in the state’s southeast. That’s because the 8K liquid crystal display (LCD) screens made at the new Foxconn campus could enable new medical solutions for surgical procedures, according to BioForward Wisconsin. “BioForward and Wisconsin’s biohealth community welcomes

Icon beats Street on Q2 earnings, acquires Mapi Group

Drug development provider Icon PLC (Nasdaq: ICLR) saw its stock jump about 6% in value today after announcing second-quarter earnings that beat analysts’ expectations. The Dublin, Ireland–based company, which serves the pharmaceutical, biotechnology and medical device industries, also said it has acquired the Mapi Group, which provides patient-centered health outcomes research and commercialisation. Financial terms of

Medtech stories we missed this week: July 21, 2017

From Second Sight’s South Korean market entry to Sanuwave’s Indonesian distribution deal, here are medtech stories we missed this week but thought were still worth mentioning. 1. Second Sight enters South Korea market Second Sight announced in a July 5 press release that it has entered the market in South Korea with the implantation of two